HER2-targeted therapy should be shifted towards an earlier line for patients with anti-EGFR-therapy naïve, HER2-amplified metastatic colorectal cancer

对于未接受过抗EGFR治疗的HER2扩增型转移性结直肠癌患者，应将HER2靶向治疗提前至治疗早期。